Quick Answer
Immunocore Holdings plc reported Total Assets of $1.07 billion for the year ending 2025.
- Immunocore Holdings plc showed an increase of +5.7% in Total Assets from 2024 to 2025.
- This data is from Immunocore Holdings plc's annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $993.99 million | Q2 2024: $1.02 billion | Q3 2024: $1.08 billion | Q1 2025: $1.03 billion | Q2 2025: $1.08 billion | Q3 2025: $1.10 billion.
- Over the full 7 years of available data (2019 to 2025), Immunocore Holdings plc's Total Assets has grown by 474.9%.
- Historical annual values: Fiscal year 2025: $1.07 billion | Fiscal year 2024: $1.01 billion | Fiscal year 2023: $597.00 million | Fiscal year 2022: $526.76 million | Fiscal year 2021: $301.77 million | Fiscal year 2020: $197.19 million | Fiscal year 2019: $185.65 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: